Wednesday, November 16, 2011

AstraZeneca's Crestor Study is Good News for the Public, Bad News for AstraZeneca - Forbes


"The findings are a blow to the Crestor franchise". Says Harlan.

Harlan M. Krumholz MD, SM is the Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health at Yale University School of Medicine, where he is Director of the Robert Wood Johnson Clinical Scholars Program.

Posted via email from Jack's posterous

No comments: